Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation of cell cycle regulators and their impact on superficial bladder cancer.

The Urologic clinics of North America - 1 Feb 2000

Rabbani F, Cordon-Cardo C

Abstract excerpt

Early cytogenetic studies in bladder cancer identify regions of chromosomal gain or loss that can be candidate loci for oncogenes and tumor suppressor genes. Oncogenes with potential prognostic significance identified in bladder cancer the RAS family, epidermal growth factor receptor, ERBB-2, MDM2, and cyclin D1. The TP53 gene has been the most thoroughly characterized tumor suppressor gene in bladder cancer,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Proto-Oncogenes
Share to Cell Cycle
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Retinoblastoma

Share to Genes, Tumor Suppressor

Share to In Situ Hybridization, Fluorescence

Share to Prognosis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 10696248
DOI: 10.1016/s0094-0143(05)70237-8

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation of cell cycle regulators and their impact on superficial bladder cancer.PMID 10696248Read ↗

p53 and retinoblastoma pathways in bladder cancer.Semantic proximity Read ↗

Molecular pathogenesis and diagnostics of bladder cancer.Semantic proximity Read ↗

Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Semantic proximity Read ↗

Genetic studies and molecular markers of bladder cancer.Semantic proximity Read ↗

Tumor suppressor loci in bladder cancer.Semantic proximity Read ↗

Genetic alterations and biological pathways in human bladder cancer pathogenesisSemantic proximity Read ↗

Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.Semantic proximity Read ↗

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerSemantic proximity Read ↗

Molecular markers for diagnosis, staging, and prognosis of bladder cancer.Semantic proximity Read ↗

What we could do now: molecular pathology of bladder cancer.Semantic proximity Read ↗

Genetic alterations in urothelial bladder carcinoma: an updated review.Semantic proximity Read ↗

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.